Wedbush Securities’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Wedbush Securities’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,068	Closed	-$235K	–	1152
2022 Q4	$235K	Sell	2,068 -2,650	-56%	-$220K	0.01%	838
2022 Q3	$292K	Sell	4,718 -271	-5%	-$18.9K	0.02%	737
2022 Q2	$398K	Sell	4,989 -464	-9%	-$43.9K	0.02%	621
2022 Q1	$574K	Buy	5,453 +148	+3%	+$14.4K	0.03%	527
2021 Q4	$572K	Buy	5,305 +1,002	+23%	+$109K	0.02%	567
2021 Q3	$471K	Buy	4,303 +1,003	+30%	+$104K	0.02%	642
2021 Q2	$309K	Buy	3,300 +357	+12%	+$32.9K	0.01%	847
2021 Q1	$271K	Buy	+2,943	New	+$248K	0.02%	856

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wedbush Securities's HZNP Position: Q1 2023 in Review

Wedbush Securities sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 2,068 shares — an estimated $235K sold.

Wedbush Securities first reported a position in HZNP in Q1 2021 and held it in 8 quarters. The position peaked at $574K in Q1 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Wedbush Securities reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Wedbush Securities sold 2,068 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $235K.
Wedbush Securities first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 8 quarters.
Wedbush Securities's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $574K in Q1 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Wedbush Securities's 13F filing for Q1 2023, filed 9 May 2023.